Vanta Bioscience Ltd (VANTABIO) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Vanta Bioscience Ltd on NSE and BSE, with an AI summary of each filing.
Submission of AGM Proceedings, Voting Results and Scrutinizers Report for the 10th Annual General Meeting
Annual General Meeting · 01 Oct 2026, 12:41 am
Submission of AGM Proceedings, Voting Results and Scrutinizer''s Report for the 10th AGM
Annual General Meeting · 01 Oct 2026, 12:38 am
Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026
Others (Uncategorized) · 05 Sept 2026, 10:27 pm
Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026
Financial Result · 31 May 2026, 2:05 am
Vanta Bioscience Reports FY26 Results and Re-appoints Managing Director Vanta Bioscience approved its audited FY26 results on 30 May'26. On a consolidated basis, FY26 revenue was Rs. 197.59 Lacs, with a net profit after tax of Rs. 10.83 Lacs, a significant turnaround from the Rs. 267.09 Lacs loss in FY25. For H2 FY26, the company posted a net profit of Rs. 192.72 Lacs. The Board also approved the re-appointment of Mr. Dopesh Raja Mulakala as Managing Director for three years, effective 18 Apr'26. The statutory auditor provided an unqualified opinion on the financial statements.
Outcome of the Board Meeting held on 30.05.2026
Outcome · 31 May 2026, 1:55 am
Vanta Bioscience Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 151 (+363.9% YoY | +401.9% QoQ) ■ EBITDA: 139 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 91.6 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: 193 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 2.71 (Loss to Profit YoY | Loss to Profit QoQ)
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
Intimation · 30 May 2026, 5:30 am
Vanta Bioscience Board Meeting to Approve FY26 Financial Results Vanta Bioscience has scheduled a Board of Directors meeting on 30 May'26 to consider and approve the standalone and consolidated audited financial results for the half-year and financial year ended 31 Mar'26. The Board will also review the statutory auditors' reports. In line with this, the trading window for designated persons is closed from 01 Apr'26 until 01 Jun'26. This meeting is crucial for assessing the company's full-year financial performance.
Clarification on Movement in Price
Others (Uncategorized) · 11 Mar 2026, 9:48 pm
Vanta Bioscience Clarifies Share Price Movement is Market-Driven Vanta Bioscience Limited, in a response to a BSE query dated 25-Feb-26, stated it is unaware of any reason for the significant movement in its share price. The company confirmed on 11-Mar-26 that it has disclosed all material information in compliance with SEBI regulations. Management asserted the share price movement is purely market-driven and that it is in no way connected with it. The company reiterated its commitment to regulatory compliance.
The Exchange has sought clarification from Vanta Bioscience Ltd on February 25, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Others (Uncategorized) · 26 Feb 2026, 12:01 am
Outcome of the Board Meeting - Appointment of Company Secretary and Compliance Officer
Others (Uncategorized) · 31 Jan 2026, 1:02 am
Vanta Bioscience Appoints New Company Secretary and Compliance Officer Vanta Bioscience Limited's Board of Directors has appointed Ms. Pooja Kothari as the new Company Secretary and Compliance Officer, effective 30 Jan'26. An Associate Member of ICSI since Dec'19, she brings four years of experience in company law and secretarial compliance from roles at private and unlisted public companies. Ms. Kothari holds a Bachelor's degree in Commerce. She has no relations with existing Directors or KMPs and has not been debarred from holding office.
Financial results for the half year ended September 30, 2025
Financial Result · 15 Nov 2025, 12:53 am
Outcome of the Board Meeting held on November 14, 2025
Outcome · 15 Nov 2025, 12:47 am
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited financial results ....
Intimation · 14 Nov 2025, 5:30 am
Resignation of Company Secretary & Compliance Officer w.e.f 01.11.2025
Change in Management · 02 Nov 2025, 12:41 am
Annual Report for FY 2024-25
Others (Uncategorized) · 01 Nov 2025, 10:54 pm
Voting Results and Scrutinizers Report
Annual General Meeting · 03 Oct 2025, 9:49 pm
Proceedings of 9th Annual General Meeting of the Company
Annual General Meeting · 01 Oct 2025, 12:22 am
Outcome of Board Meeting held on 06.09.2025
Others (Uncategorized) · 07 Sept 2025, 4:53 am
Financials for the half year and year ended 31.03.2025
Financial Result · 02 Aug 2025, 3:26 am
Outcome of the Board Meeting held on 01.08.2025
Outcome · 02 Aug 2025, 3:04 am
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve the financial results of the ....
Rescheduled / Cancelled · 01 Aug 2025, 5:30 am
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2025 ,inter alia, to consider and approve the audited financial results ....
Intimation · 19 Jul 2025, 5:30 am
Rejection of Promoter Reclassification Application
Others (Uncategorized) · 17 Jun 2025, 4:27 am
The Board Meeting to be held on 30/05/2025 Stands Cancelled.
Rescheduled / Cancelled · 30 May 2025, 12:16 am
Delay in Submission of Financial Results for the period ended March 31, 2025
Financial Result · 30 May 2025, 12:06 am
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the audited financial results ....
Intimation · 30 May 2025, 5:30 am